No Data
Relay's TeamTranslate Removes Language Barriers for Frontline Teams and Helps Ease Labor Shortages
Breakthrough AI functionality allows real-time language translation via talk or text for teams using RelayRALEIGH, N.C., May 23, 2024 /PRNewswire/ -- Since launching in 2020, Relay has enabled face-t
Relay Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and
Relay Therapeutics Upgraded by Barclays Ahead of Data Readout
Relay Therapeutics Raised to Overweight From Equal-Weight by Barclays
Relay Therapeutics Raised to Overweight From Equal-Weight by Barclays
Barclays Upgrades Relay Therapeutics to Overweight, Maintains Price Target to $15
Barclays analyst Peter Lawson upgrades Relay Therapeutics (NASDAQ:RLAY) from Equal-Weight to Overweight and maintains the price target from $15 to $15.